AGENDA
09:00-09:10 AM
Welcoming Remarks
Yanhong Lin and Feng Han, Managing Partners, CTIC Capital
09:10-09:40 AM
Keynote: From Nanotechnology to mRNA Vaccines: How Overcoming Skepticism and Barriers Led to New Cancer Treatments and Ways to Tackle A Global Health Challenge
Bob Langer, Institute Professor, MIT
09:10-09:40 AM
Fireside Chat: TBD
09:40-10:30 AM
Panel Discussion: Global Healthcare Investment: Navigating Challenges and Market Dynamics
Panel Lead, Helen Chen, Global Sector Co-Head, Healthcare and Life Science, LEK
Doug Fisher, Partner, Revelation Partners
James Huang, Founding Managing Partner, Panacea Venture
Karen Liu, Founding Partner, 3E Bioventures Capital
Chong Xu, Partner, F-Prime Capital
James Zhao, Founding Partner, LYFE Capital
10:30-11:00 AM
Company Presenting
11:00-11:30 AM
Company Presenting
01:00-01:45 PM
Panel Discussion: The Next Wave of Innovation in Medicine:
Panel Lead: TBD
John Lepore, CEO-Partner Flagship Pioneering, ProFound Therapeutics, Former Senior Vice President, Head of Research, GSK
Stacy Feld, Head, Johnson & Johnson Innovation, West North America
01:45-02:15 PM
Company Presenting
02:15-02:45 PM
Company Presenting
02:45-03:00 PM
Break
03:00-03:30 PM
Company Presenting
03:30-04:00 PM
Panel Discussion: The Next Leap in Medicine: AI’s Emerging Role in Drug Discovery and Clinical Applications
Panel Lead: Gini Deshpande, Founder and CEO of NuMedii
David Berry, General Partner, Flagship Pioneering
Atul Butte, Professor, University of California San Francisco
Matthew Lungren, Chief Medical Information Officer, Microsoft
04:00-04:50 PM
Panel Discussion: Innovation Insights: Large Pharma’s Top Picks for Future Success: Quest for Cutting Edge
Panel Lead: Wendy Pan, Partner, Goodwin Procter LLP
Niels Emmerich, Vice President, Global S&E and Alliances, Abbvie
Liangsu Wang, Vice President, J&J Innovation – CVD, Metabolism, Retina, and PH
Ryan Watts, Co-Founder and CEO, Denali Therapeutics
04:50-05:00 PM
Closing Remarks
Victor Shi, Managing Partner, Serica Partners
